[{"address1": "2656 State Street", "city": "Carlsbad", "state": "CA", "zip": "92008", "country": "United States", "phone": "619 728 4760", "website": "https://tyra.bio", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SN\u00c5P, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.", "fullTimeEmployees": 60, "companyOfficers": [{"maxAge": 1, "name": "Dr. Todd  Harris Ph.D.", "age": 45, "title": "Co-Founder, President, CEO, Secretary, Treasurer & Director", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 1067050, "exercisedValue": 0, "unexercisedValue": 7050750}, {"maxAge": 1, "name": "Mr. Daniel  Bensen", "age": 49, "title": "Co-Founder & COO", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 737643, "exercisedValue": 0, "unexercisedValue": 4335961}, {"maxAge": 1, "name": "Dr. Douglas  Warner M.D.", "age": 52, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 627900, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alan  Fuhrman CPA", "age": 67, "title": "Chief Financial Officer", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 763093, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert L. Hudkins Ph.D.", "age": 69, "title": "Chief Technology Officer", "yearBorn": 1955, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ronald V. Swanson Ph.D.", "age": 61, "title": "Chief Scientific Officer", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 536188, "exercisedValue": 0, "unexercisedValue": 298928}, {"maxAge": 1, "name": "Mr. Ali D. Fawaz J.D.", "title": "General Counsel", "fiscalYear": 2024, "totalPay": 629230, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sarah  Honig", "title": "Senior VP of Corporate Development & Strategy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Liz  Pagano", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Piyush R. Patel Ph.D.", "age": 59, "title": "Chief Development Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 21.0, "open": 20.74, "dayLow": 19.18, "dayHigh": 21.805, "regularMarketPreviousClose": 21.0, "regularMarketOpen": 20.74, "regularMarketDayLow": 19.18, "regularMarketDayHigh": 21.805, "payoutRatio": 0.0, "beta": 1.123, "forwardPE": -10.455446, "volume": 1454447, "regularMarketVolume": 1454447, "averageVolume": 280326, "averageVolume10days": 580130, "averageDailyVolume10Day": 580130, "bid": 21.06, "ask": 25.24, "bidSize": 1, "askSize": 2, "marketCap": 1127218688, "fiftyTwoWeekLow": 6.42, "fiftyTwoWeekHigh": 21.81, "allTimeHigh": 31.36, "allTimeLow": 4.93, "fiftyDayAverage": 14.4728, "twoHundredDayAverage": 11.49685, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 858213696, "profitMargins": 0.0, "floatShares": 17569561, "sharesOutstanding": 53372098, "sharesShort": 4706779, "sharesShortPriorMonth": 5915988, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.088199995, "heldPercentInsiders": 0.03194, "heldPercentInstitutions": 1.04712, "shortRatio": 20.34, "shortPercentOfFloat": 0.1291, "impliedSharesOutstanding": 53372098, "bookValue": 5.261, "priceToBook": 4.014446, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -111684000, "trailingEps": -1.88, "forwardEps": -2.02, "enterpriseToEbitda": -6.842, "52WeekChange": 0.30531526, "SandP52WeekChange": 0.1028198, "quoteType": "EQUITY", "currentPrice": 21.12, "targetHighPrice": 36.0, "targetLowPrice": 28.0, "targetMeanPrice": 32.0, "targetMedianPrice": 32.0, "recommendationMean": 1.125, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 274924000, "totalCashPerShare": 5.151, "ebitda": -125432000, "totalDebt": 5919000, "quickRatio": 17.452, "currentRatio": 17.71, "debtToEquity": 2.11, "returnOnAssets": -0.23076999, "returnOnEquity": -0.34749, "freeCashflow": -48557752, "operatingCashflow": -91108000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TYRA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketPrice": 21.12, "postMarketChange": 0.0, "regularMarketChange": 0.12000084, "regularMarketDayRange": "19.18 - 21.805", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 280326, "fiftyTwoWeekLowChange": 14.700001, "fiftyTwoWeekLowChangePercent": 2.2897198, "fiftyTwoWeekRange": "6.42 - 21.81", "fiftyTwoWeekHighChange": -0.6899986, "fiftyTwoWeekHighChangePercent": -0.0316368, "fiftyTwoWeekChangePercent": 30.531525, "shortName": "Tyra Biosciences, Inc.", "longName": "Tyra Biosciences, Inc.", "corporateActions": [], "postMarketTime": 1763765437, "regularMarketTime": 1763758801, "exchange": "NMS", "messageBoardId": "finmb_650787124", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.5714326, "regularMarketPrice": 21.12, "earningsTimestampStart": 1762462800, "earningsTimestampEnd": 1762462800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.88, "epsForward": -2.02, "epsCurrentYear": -1.984, "priceEpsCurrentYear": -10.645162, "fiftyDayAverageChange": 6.6472006, "fiftyDayAverageChangePercent": 0.4592892, "twoHundredDayAverageChange": 9.623151, "twoHundredDayAverageChangePercent": 0.837025, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-09-15", "averageAnalystRating": "1.1 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1631712600000, "postMarketChangePercent": 0.0, "trailingPegRatio": null, "__fetch_time": "2025-11-22"}]